Company

Resalis Therapeutics

Biotechnology Research Piedmont, IT 11 employees GNTA

Employees: 11
Contacts: 3
Emails: 3
Phones: 2

www.resalistherapeutics.com LinkedIn Crunchbase

Resalis Therapeutics Overview

Headquarters: Piedmont, IT
Website: www.resalistherapeutics.com
Industry: Biotechnology Research
Employees: 11
Founded: 2021
Stock Symbol: GNTA
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

delivers as expected. Working closely with our leadership

About Resalis Therapeutics

Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.

Resalis Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Resalis Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Almut Nitsche		Germany	Email
Claus Andersson	Investing in Life Sciences - General	Copenhagen, Capital Region of Denmark, Denmark	Email Phone
Pietro Puglisi	Partner at Claris Ventures		View
Alessandro Toniolo	Resalis’ Transformative Metabolic	Italy	Email Phone